4D Molecular Therapeutics (FDMT) Short Interest Ratio & Short Volume → Prepare for a Recession Unlike Any Other (From American Hartford Gold Group) (Ad) Free FDMT Stock Alerts $23.12 +0.55 (+2.44%) (As of 12:34 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends 4D Molecular Therapeutics Short Interest DataCurrent Short Interest9,650,000 sharesPrevious Short Interest9,620,000 sharesChange Vs. Previous Month+0.31%Dollar Volume Sold Short$246.85 millionShort Interest Ratio15.8 Days to CoverLast Record DateMay 15, 2024Outstanding Shares51,700,000 sharesPercentage of Shares Shorted18.67%Today's Trading Volume280,412 sharesAverage Trading Volume884,543 sharesToday's Volume Vs. Average32% Short Selling 4D Molecular Therapeutics ? Sign up to receive the latest short interest report for 4D Molecular Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartFDMT Short Interest Over TimeFDMT Days to Cover Over TimeFDMT Percentage of Float Shorted Over Time Ad Augury ResearchBreaking - The US Gov. Seized CITGODo you want an investment that can double or triple your money in the next three months? The US Court is currently auctioning off CITGO (the winning bid will be announced on July 22nd).Get all the details here. 4D Molecular Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/20249,650,000 shares $246.85 million +0.3%N/A15.8 $25.58 4/30/20249,620,000 shares $230.21 million -2.1%N/A11.1 $23.93 4/15/20249,830,000 shares $258.04 million +5.5%N/A8.3 $26.25 3/31/20249,320,000 shares $296.94 million +9.7%N/A8 $31.86 3/15/20248,500,000 shares $267.84 million +1.9%N/A7.7 $31.51 2/29/20248,340,000 shares $233.69 million +18.1%N/A7.8 $28.02 Get the Latest News and Ratings for FDMT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for 4D Molecular Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 2/15/20247,060,000 shares $195.49 million +83.9%N/A7.1 $27.69 1/31/20243,840,000 shares $66.24 million +33.3%N/A4.3 $17.25 1/15/20242,880,000 shares $54.14 million -10.6%N/A7.7 $18.80 12/31/20233,220,000 shares $65.24 million -18.1%N/A8.8 $20.26 12/15/20233,930,000 shares $69.80 million +9.2%N/A10.8 $17.76 11/30/20233,600,000 shares $45.79 million -4.5%N/A10.6 $12.72 11/15/20233,770,000 shares $41.70 million +7.4%N/A11.2 $11.06 10/31/20233,510,000 shares $37.70 million -14.4%N/A10.6 $10.74 10/15/20234,100,000 shares $42.89 million +4.3%N/A13 $10.46 9/30/20233,930,000 shares $50.03 million +6.5%N/A13.6 $12.73 9/15/20233,690,000 shares $57.42 million +3.4%N/A12.3 $15.56 8/31/20233,570,000 shares $58.12 million No ChangeN/A9.4 $16.28 8/15/20233,570,000 shares $59.48 million +15.5%N/A8.6 $16.66 7/31/20233,090,000 shares $56.55 million -0.6%N/A6.5 $18.30 7/15/20233,110,000 shares $58.84 million -11.4%N/A5.3 $18.92 6/30/20233,510,000 shares $63.43 million +2.6%N/A5.5 $18.07 6/15/20233,420,000 shares $71.82 million +10.0%N/A5.4 $21.00 5/31/20233,110,000 shares $57.10 million +4.7%N/A5.2 $18.36 5/15/20232,970,000 shares $52.93 million +4.6%N/A5.4 $17.82 4/30/20232,840,000 shares $51.15 million -10.1%N/A5.6 $18.01 4/15/20233,160,000 shares $51.10 million +1.3%N/A8 $16.17 3/31/20233,120,000 shares $53.63 million +19.5%N/A8.8 $17.19 3/15/20232,610,000 shares $45.34 million +23.7%N/A7.6 $17.37 2/28/20232,110,000 shares $40.60 million -5.4%N/A6.3 $19.24 2/15/20232,230,000 shares $41.19 million +2.8%N/A6.1 $18.47 1/31/20232,170,000 shares $45.68 million -3.6%N/A4.5 $21.05 1/15/20232,250,000 shares $49.57 million +8.7%N/A4.4 $22.03 12/30/20222,070,000 shares $45.97 million +11.9%N/A3.9 $22.21 12/15/20221,850,000 shares $42.72 million -19.2%N/A3.2 $23.09 11/30/20222,290,000 shares $55.35 million -15.2%N/A4.2 $24.17 11/15/20222,700,000 shares $50.46 million -6.9%N/A5.5 $18.69 10/31/20222,900,000 shares $25.11 million -1.7%N/A9.1 $8.66 10/15/20222,950,000 shares $20.74 million +87.9%N/A10.6 $7.03 9/30/20221,570,000 shares $12.62 million +7.5%N/A6.3 $8.04He Is Giving Away Bitcoin (Ad)And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.>> Register right here 9/15/20221,460,000 shares $13.49 million -2.7%N/A7.6 $9.24 8/31/20221,500,000 shares $11.79 million -3.9%N/A6.5 $7.86 8/15/20221,560,000 shares $14.90 million -3.7%N/A6.5 $9.55 7/31/20221,620,000 shares $15.23 million -5.3%N/A6.1 $9.40 7/15/20221,710,000 shares $17.24 million -2.8%N/A6.3 $10.08 6/30/20221,760,000 shares $12.28 million -17.4%N/A6.4 $6.98 6/15/20222,130,000 shares $12.57 million +7.6%N/A8 $5.90 5/31/20221,980,000 shares $15.03 million +4.8%N/A9.7 $7.59 5/15/20221,890,000 shares $17.03 million -3.6%N/A9.1 $9.01 4/30/20221,960,000 shares $23.34 million +3.2%N/A9.7 $11.91 4/15/20221,900,000 shares $25.12 million +5.6%N/A9 $13.22 3/31/20221,800,000 shares $27.22 million +1.1%N/A8.4 $15.12 3/15/20221,780,000 shares $25.04 million -0.6%N/A8 $14.07 2/28/20221,790,000 shares $24.52 million +7.8%N/A6.2 $13.70 2/15/20221,660,000 shares $25.78 million +6.4%N/A5.8 $15.53 1/31/20221,560,000 shares $24.65 million +10.6%5.9%5.5 $15.80 1/15/20221,410,000 shares $23.96 million +0.7%5.3%4.4 $16.99 12/31/20211,400,000 shares $30.72 million +64.1%5.3%4.5 $21.94 12/15/2021853,100 shares $17.71 million -3.1%3.2%2.7 $20.76 11/30/2021880,000 shares $20.24 million -25.4%3.5%3.4 $23.00 11/15/20211,180,000 shares $28.31 million -26.3%4.6%4.6 $23.99 10/29/20211,600,000 shares $38.45 million -1.2%6.3%6.8 $24.03 10/15/20211,620,000 shares $44.26 million +1.3%7.6%9.7 $27.32 9/30/20211,600,000 shares $43.15 million +30.1%7.5%10.9 $26.97 9/15/20211,230,000 shares $41.96 million +18.3%5.8%7.6 $34.11 8/31/20211,040,000 shares $31.77 million +2.0%4.9%7.8 $30.55 8/13/20211,020,000 shares $27.55 million +2.1%4.8%8.2 $27.01 7/30/2021999,400 shares $24.86 million +0.4%4.8%7.9 $24.87 7/15/2021995,000 shares $23.19 million +5.1%4.8%7.4 $23.31 6/30/2021947,200 shares $22.81 million -6.2%4.6%6.8 $24.08 6/15/20211,010,000 shares $27.47 million +14.3%4.9%7.6 $27.20 5/28/2021883,800 shares $23.47 million +8.1%4.3%6.2 $26.56 5/14/2021817,500 shares $21.60 million -1.2%3.9%5.2 $26.42 4/30/2021827,700 shares $31.75 million +21.5%4.0%5.3 $38.36 4/15/2021681,000 shares $25.66 million -9.4%3.3%4.3 $37.68 3/31/2021751,200 shares $28.96 million +63.1%3.6%4.6 $38.55 3/15/2021460,500 shares $23.20 million +1.3%2.2%2.7 $50.38 2/26/2021454,500 shares $19.68 million +72.0%2.2%2.1 $43.29 2/12/2021264,300 shares $13.92 million +67.9%1.4%1.2 $52.67 1/29/2021157,400 shares $6.61 million +55.1%0.8%0.6 $42.00 1/15/2021101,500 shares $4.67 million No Change0.5%0.4 $46.00 FDMT Short Interest - Frequently Asked Questions What is 4D Molecular Therapeutics' current short interest? Short interest is the volume of 4D Molecular Therapeutics shares that have been sold short but have not yet been covered or closed out. As of May 15th, investors have sold 9,650,000 shares of FDMT short. Learn More on 4D Molecular Therapeutics' current short interest. What is a good short interest ratio for 4D Molecular Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. FDMT shares currently have a short interest ratio of 16.0. Learn More on 4D Molecular Therapeutics's short interest ratio. Which institutional investors are shorting 4D Molecular Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of 4D Molecular Therapeutics: Ikarian Capital LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is 4D Molecular Therapeutics' short interest increasing or decreasing? 4D Molecular Therapeutics saw a increase in short interest during the month of May. As of May 15th, there was short interest totaling 9,650,000 shares, an increase of 0.3% from the previous total of 9,620,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does 4D Molecular Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to 4D Molecular Therapeutics: Krystal Biotech, Inc. (9.84%), CRISPR Therapeutics AG (18.05%), ImmunityBio, Inc. (38.03%), Immunovant, Inc. (15.25%), SpringWorks Therapeutics, Inc. (14.43%), Arcellx, Inc. (9.67%), Apogee Therapeutics, Inc. (12.30%), Denali Therapeutics Inc. (8.09%), Iovance Biotherapeutics, Inc. (22.90%), Immunocore Holdings plc (10.66%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks. What does it mean to sell short 4D Molecular Therapeutics stock? Short selling FDMT is an investing strategy that aims to generate trading profit from 4D Molecular Therapeutics as its price is falling. FDMT shares are trading down $0.19 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against 4D Molecular Therapeutics? A short squeeze for 4D Molecular Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of FDMT, which in turn drives the price of the stock up even further. How often is 4D Molecular Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including FDMT, twice per month. The most recent reporting period available is May, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Krystal Biotech Short Interest CRISPR Therapeutics Short Interest ImmunityBio Short Interest Immunovant Short Interest SpringWorks Therapeutics Short Interest Arcellx Short Interest Apogee Therapeutics Short Interest Denali Therapeutics Short Interest Iovance Biotherapeutics Short Interest Immunocore Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:FDMT) was last updated on 6/7/2024 by MarketBeat.com Staff From Our PartnersCollapse of the Petrodollar The death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredProtect Your Bank Account Before It’s Too LateFor months I’ve been warning about the federal government’s terrifying new program to control every American’s...Weiss Ratings | SponsoredAlert: Your Bank is Dying – Act Now or Lose Everything!Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put...Priority Gold | SponsoredPrepare for a Recession Unlike Any OtherDave Ramsey Is Dangerously Wrong And Here’s Why>> Asked whether we’re on the cusp of a US Dollar crash, Dav...American Hartford Gold Group | SponsoredBreaking - The US Gov. Seized CITGODo you want an investment that can double or triple your money in the next three months? The US Court is cu...Augury Research | SponsoredHe Is Giving Away BitcoinAnd my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a v...Crypto Swap Profits | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding 4D Molecular Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share 4D Molecular Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.